Ivermectin Litigation is Forcing Judges to Make Medical Decisions for COVID-19 Patients
Courts across the country have allowed hospitals to let COVID-19 patients undergo treatment with Ivermectin. Courts are overruling the warning that the Food and Drug Administration, the Centers for Disease Control and Prevention, the World Health Organization and the American Medical Association have issued against using the drug to treat COVID-19. The use of the unregulated drug has caused many lawsuits to emerge, and is generating concern among health-care lawyers.
“You could have just tried something else and chose not to,” Davis Goldman Partner Aaron Davis told Daily Business Review. “There’s a reason why standards of care are developed and why certain agencies approve medication, and it’s because they go through a series of testing and safety profiles.”
Latest Posts
by Davis & GoldmanPartner Kimberly Cook Attends Miami-Dade Florida Association for Women Lawyers’ 11th Annual Trial Skills Workshop
Davis Goldman Partner Kimberly Cook recently took part, as distinguished faculty, in the Miami-Dade Florida Association for Women Lawyers’ 11th Annual Trial...
by Davis & GoldmanControversial Tort Measure Moves to Florida House Judiciary Committee
After approval by the Civil Justice Subcommittee in February, the Florida House of Representatives Judiciary Committee will take up the civil remedies bill....
by Davis GoldmanNavigating the Civil Litigation System: Understanding the Rights of Foreign Nationals
In partnership with Canero Lammers Fadul Acevedo Immigration Law Group, Davis Goldman Co-Managing Partner Aaron Davis, Associate Michael Bild, and Law Clerk...